Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats by Jana Ruda-Kucerova et al.
ORIGINAL RESEARCH
published: 06 July 2015
doi: 10.3389/fpsyt.2015.00091
Edited by:
Miriam Melis,
University of Cagliari, Italy
Reviewed by:
Angelo Giovanni Icro Maremmani,
University of Pisa, Italy
Cristina Cadoni,
National Research Council, Italy
*Correspondence:
Jana Ruda-Kucerova,
CEITEC – Central European Institute
of Technology, Masaryk University,
Kamenice 5, Brno 625 00,
Czech Republic
jkucer@med.muni.cz
Specialty section:
This article was submitted to
Addictive Disorders and Behavioral
Dyscontrol, a section of the journal
Frontiers in Psychiatry
Received: 03 April 2015
Accepted: 09 June 2015
Published: 06 July 2015
Citation:
Ruda-Kucerova J, Amchova P,
Babinska Z, Dusek L, Micale V and
Sulcova A (2015) Sex differences in
the reinstatement of
methamphetamine seeking
after forced abstinence in
Sprague-Dawley rats.
Front. Psychiatry 6:91.
doi: 10.3389/fpsyt.2015.00091
Sex differences in the reinstatement
of methamphetamine seeking
after forced abstinence in
Sprague-Dawley rats
Jana Ruda-Kucerova1,2*, Petra Amchova1,2, Zuzana Babinska1,2, Ladislav Dusek 3,
Vincenzo Micale1,4 and Alexandra Sulcova1
1 Experimental and Applied Neuropsychopharmacology Group, Central European Institute of Technology (CEITEC), Masaryk
University, Brno, Czech Republic, 2 Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech
Republic, 3 Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic, 4 Section
of Pharmacology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania,
Catania, Italy
Preventing relapse to drug abuse is one of the struggles faced by clinicians in order to
treat patients with substance use disorders (DSM-5). There is a large body of clinical
evidence suggesting differential characteristics of the disorder in men and women, which
is in line with preclinical findings as well. The aim of this study was to assess differences
in relapse-like behavior in methamphetamine (METH) seeking after a period of forced
abstinence, which simulates the real clinical situation very well. Findings from such
study might add new insights in gender differences in relapse mechanisms to previous
studies, which employ a classical drug or cue-induced reinstatement procedure following
the extinction training. Adult male and female Sprague-Dawley rats were used in IV
self-administration procedure conducted in operant boxes using nose-poke operandi
(Coulborn Instruments, USA). Active nose-poke resulted in activation of the infusion pump
to deliver one intravenous infusion of METH (0.08mg/kg). After baseline drug intake was
established (maintenance phase), a period of forced abstinence was initiated and rats
were kept singly in their home cages for 14 days. Finally, one reinstatement session
in operant boxes was conducted. Females were found to self-administer significantly
lower dose of METH. The relapse rate was assessed as a number of active nose-
pokes during the reinstatement session, expressed as a percentage of active nose-poking
during the maintenance phase. Females displayed approximately 300% of active nose-
pokes compared to 50% in males. This indicates higher vulnerability to relapse of METH
seeking behavior in female rats. This effect was detected in all females, independently
of current phase of their estrous cycle. Therefore, this paradigm using operant drug
self-administration and reinstatement of drug-seeking after forced abstinence model can
be used for preclinical screening for potential new anti-relapse medications specific for
women.
Keywords: methamphetamine, reinstatement of drug-seeking behavior, forced abstinence, sex/gender
differences, Sprague-Dawley rats
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Introduction
Methamphetamine (METH) addiction is a serious psychosocial
problem, which leads to organic harm of the body as well as
distortion of the normal functioning of affected people within
the society and family. There is a large body of clinical evidence
suggesting differential characteristics of the disorder in men and
women. Despite the absolute number of female METH abusers
being lower than the male ones, women usually appear more
dependent, show higher escalation rates (1, 2) and most impor-
tantly tend to experience more frequent relapses (3, 4). These
gender specific differences require specific treatment strategies
for men and women (5–7). This particularly applies to relapse-
prevention, which represents a key treatment challenge especially
for women (8).
The preclinical approach to model drug addiction with the
highest validity is usually considered as the operant drug self
administration. To mimic relapse in this paradigm, a period of
extinction procedure can be employed when the animal still has
a regular access to the operant box but the drug delivered by infu-
sion pump is replaced by vehicle. After certain number of sessions,
the subject stops to respond to the active operandum (e.g., lever or
nose-poke). After reaching a specific extinction criteria (number
of active/inactive responses lower than a set number), one last
session is conducted and the reinstatement of the drug-seeking
behavior is primed by an environmental factor (stress, cues) or a
drug dose. Such studies have repeatedly shown female rats to be
more vulnerable to drug-primed relapse of METH seeking behav-
ior at conditions of time limited sessions (2 h), whichmimic rather
consummatory behavior, as well as prolonged self-administration
sessions. This is considered to provide a better model for loss of
control over drug taking, leading to escalation of drug consump-
tion (9) known from a clinical situation (3). Similarly, a higher
relapse-like behavior was found in female rats after priming by
conditioned cue and to even higher extent by METH dose (10).
Earlier, analogous results were reported in studies with cocaine
(11, 12) and fentanyl (13).
However, this paradigm does not mimic the human treatment
very well, because the patient usually discontinues the drug abuse
in the drug rehabilitation center and for some time does not
have access to the drug-related environments. Therefore, a forced
abstinence model was developed where the animal does not have
access to the operant box and is kept in the home cage for some
time (14–16); thus, the motivation of drug response behavior is
not influenced by any training procedures.
Furthermore, many preclinical studies, which assess sex-
dependent differences, isolate the hormonal effect either by
ovariectomy and subsequent hormonal supplementation (17, 18)
or by constant tracking of the estrous cycle phase (10, 19). These
approaches already explained extensively the role of gonadal hor-
mones in the reward processes showing enhancement of drug
intake by estradiol (17, 18, 20–22) and attenuation of drug seek-
ing by progesterone (4, 23). However, the possibilities of clinical
applications of these findings are limited, so far only progesterone
was tested as a treatment for nicotine relapse in women (24) and
such treatment would have many undesirable side effects. Con-
sequently, an ideal animal model with high face, construct, and
predictive validity for testing new relapse-prevention treatments
should not be based on hormonal levels only.
The intact animals (males and freely cycling females) showed
no sex differences to effects of amphetamines in the animal model
of conditioned place preference (CPP) (25, 26). Interestingly, CPP
for METH did not occur in ovariectomized rats but developed in
females treated with estradiol (27). Therefore, gender differences
in the CPP paradigm might be biased by fluctuating hormonal
levels in intact females. However, results supporting higher vul-
nerability toMETH in intact female ratswere reported too. Female
rats displayed higher increase of locomotor activity, which lasted
for longer time and had higher scores of stereotypies than male
rats (28). These results indicate the sex differences may depend,
besides hormonal influences, also on different pharmacokinetic
processes in females (29).
Therefore, the aim of this study was to assess gender differ-
ences in all stages of operant IV self-administration of METH
in male and female rats while the gonads of all animals were
kept intact assuring physiological estrous cycle in females. We
expected a higher variability in the female group, especially in
the reinstatement of METH seeking behavior due to different
hormonal stages. However, we hypothesized that this variability
may be overpowered by all other significant gender differences.
Furthermore, we assessed possible gender differences in acqui-
sition and maintenance of food self-administration in order to
compare the operant behavior toward natural reward (food) and
the drug of abuse.
Materials and Methods
Animals
Eight-week-old male and female albino Sprague-Dawley rats
weighing 175–200 g (females) and 200–225 g (males) at the begin-
ning of the experiment were purchased from Charles River (Ger-
many). The rats were housed individually in standard rat plastic
cages, the experiments on males and females were performed
separately, to assure the self-administration room is dedicated
to one gender at a time only. Environmental conditions during
the whole study were constant: relative humidity 50–60%, tem-
perature 23 1°C, inverted 12-h light–dark cycle (6 a.m. to 6
p.m. darkness). Food and water were available ad libitum. All
experiments were conducted in accordance with all relevant laws
and regulations of animal care and welfare. The experimental
protocol was approved by the Animal Care Committee of the
Masaryk University, Faculty of Medicine, Czech Republic, and
carried out under the EuropeanCommunity guidelines for the use
of experimental animals.
Drugs and Treatments
Methamphetamine from Sigma Chemical, Co., St Louis, MO,
USA available in the operant cage for IV self-administration was
0.08mg/kg per infusion with the maximum number of infusions
obtainable in one session set to 50. The solutions were prepared
for specific animals depending on their body weights rounded
to the closest category of 250, 300, 350 g, etc. This paradigm is
adapted from Emmett-Oglesby MW (Fort Worth, TX, USA) (30)
and routinely used in our laboratory (17, 31–33).
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Locomotor Activity Test
After adaptation period at the beginning of the study basal behav-
ioral profile was assessed in both males and females. In brightly
lit room, rats were individually tested for locomotor activity using
the Actitrack system (Panlab, Spain) as previously described (34,
35). Each Plexiglas arena (45 cm 45 cm 30 cm) was equipped
with 2 frames equipped with photocells located one above another
2 and 12 cm above the cage floor. Each animal was placed in the
center of arena and the spontaneous behavior was tracked for
10min. During the test, the horizontal locomotor activity (the tra-
jectory as calculated by the system from beam interruptions that
occurred in the horizontal sensors) and vertical activity (number
of rearing episodes breaking the photocell beams of the upper
frame) were recorded. At the end of the session, animals were
returned to their home cage and arenas were wiped with 1% acetic
acid to avoid olfactory cues.
Intravenous Drug Self-Administration Surgery
Animals were deeply anesthetized with i.p. injections of 50mg/kg
ketamine plus 8mg/kg xylazine. Under aseptic conditions, a per-
manent intracardiac silastic catheter was implanted through the
external jugular vein to the right atrium. The outer part of the
catheter exited the skin in the midscapular area. After surgery,
each animal was allowed for recovery, individually in its home
cage with food and water freely available. Since the implantation,
the catheters were flushed daily by heparinized cephazoline (Vul-
mizolin 1.0 g) solution followed by 0.1ml of a heparinized (1%)
sterile saline solution to prevent infection and occlusion of the
catheter. During recovery, changes in general behavior and body
weight were monitored. When a catheter was found to be blocked
or damaged, the animal was excluded from the analysis. At the end
of the study, there were n= 6 male and n= 6 female rats included
to the analysis.
Intravenous Self-Administration Protocol
Methamphetamine self-administration was conducted as
previously described (17, 32) in 10 standard experimental
boxes (30 cm 25 cm 30 cm, Coulbourn Instruments, USA)
using nose-poking as operandum under a FR-1 schedule of
reinforcement, i.e., animal had to make 1 nose-poke on the active
hole to obtain a single drug infusion. Each cage was provided
with two nose-poke holes allocated on one side and programed by
software Graphic State Notation 3.03 (Coulbourn Instruments,
USA). Nose-pokes in the active hole led to the activation of the
infusion pump and administration of a single infusion followed
by a 10 s timeout, while nose-poke stimulation was recorded but
not rewarded. The cage was illuminated by a house light during
the session. The light was flashing when administering infusion
and off during the time-out period. Self-administration sessions
lasted 90min and took place 7 days/week for 2weeks in total
between 8 a.m. and 3 p.m. during the dark period of the inverted
light–dark cycle.
After 14 days of stable METH intake, the maintenance phase
was terminated and rats were returned to their home cages for
the 14 days of the forced abstinence period. On day 15, rats
were placed into self-administration chambers for the last 90min
reinstatement session. The numbers of responses on the active
drug-paired nose-poke and the inactive nose-poke were recorded
but the drug was not delivered. Responses on the active nose-poke
are considered to reflect the reinstatement of drug-seeking behav-
ior, while responses on inactive nose-poke reflect non-specific
locomotor and exploratory activity.
Food Self-Administration Protocol
Food self-administration was conducted in the same experimen-
tal boxes as METH study (Coulbourn Instruments, USA) in a
separate batch of animals. Under the FR-1 schedule of reinforce-
ment 1 nose-poke lead to activation of a feeder and delivery
of a single palatable pellet (BioServ, sweet dustless rodent pel-
lets, F0021-Purified Casein Based Formula – 45mg). The cage
was illuminated by a house light during the whole session. Self-
administration sessions lasted 30min during the dark period of
the inverted light–dark cycle.
Statistical Data Analysis
Primary data were summarized using arithmetic mean and SE
of the mean estimate. Behavioral data were analyzed by t-test.
IV METH self-administration data during the 14 days of main-
tenance were analyzed at individual days by t-test and at 5-day
intervals by mixed ANOVAmodel with Greenhouse–Geisser cor-
rection. Acquisition of food self-administration was evaluated by
comparison of mean day of reaching 70% preference of active
nose poke by Mann–Whitney U test. Maintenance of food self-
administrationwas analyzed at individual days by t-test. Statistical
analyses were computed using SPSS 19.0.1 (IBM Corporation,
2010). A p-value <0.05 was recognized as boundary of statistical
significance in all applied tests.
Results
Basal Locomotor Characteristics
Before starting the IV self-administration protocol, basal loco-
motor and exploratory activity was assessed in both males and
females to exclude the possibility that these characteristics would
lead to different drug taking behavior. Horizontal and vertical
locomotor activity was measured and a proportion of each in the
inner zone of the arena was calculated in order to evaluate differ-
ences in the status of anxiety in male and female rats. Figure 1
illustrates the results on total distance traveled, vertical activity
(number of rearing episodes), and inner part of arena preference.
There were no basal behavioral differences between the sexes,
which could contribute to dissimilar behavior in the operant cage.
As expected, both sexes avoided the central part of the arena,
which represents normal rodent behavior and neither one shows
highly anxiogenic behavior or locomotor hyper- or hypo-activity.
Acquisition and Maintenance of
Methamphetamine Self-Administration in Male
and Female Rats
The acquisition and maintenance of METH taking behavior
were assessed, first, in terms of mean number of infusions
self-administered per session and, second, by the mean METH
dose per session in milligram per kilogram. Figure 2A shows
number of infusions obtained per daily session andmean number
of infusions during the entire acquisition phase inmale and female
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FIGURE 1 |Male and female rats have the same basal behavioral
profile. Total distance traveled (in centimeters), number of rearing
episodes (vertical activity), and % of preference of the central part of the
arena did not reveal any gender difference. Data are shown as means
(SEM), t-test, n.s.
rats during the acquisition phase of METH self-administration
training. ANOVA revealed no significant effects over the whole
period. However, when the number of infusions was converted
to a METH dose per kilogram of body weight, males were
found to self-administer higher dose at the end of the acquisi-
tion phase as compared to females. More specifically, as depicted
in the Figure 2B, mean METH intake during the last 5 days
of training was significantly higher in males than in females,
i.e., 2.5 and 1.5mg/kg, respectively (mixed ANOVA model:
p= 0.038).
Reinstatement of Methamphetamine
Self-Administration in Male and Female Rats
After the 2-week-long period of forced abstinence one last rein-
statement session was performed with no drug availability. The
only measure of the drug-seeking behavior is the number of
active operandum responses. This number was converted to
a percent of mean basal nose-poking (14 days of acquisition
and maintenance). There was a massive difference between the
sexes recorded: male rats showed mean percent of responding
48.3% whereas females showed 295.7% (mixed ANOVA model,
p= 0.001). Results are reported on the Figure 3.
Acquisition of Food Self-Administration in Male
and Female Rats
The acquisition of food taking behavior (sweet pellets) was
assessed in terms of day when the animals started to prefer the
active nose-poke more than 70%. Figure 4A shows the develop-
ment of active nose poke preference (%) over all sessions in male
and female rats. Figure 4B reports the mean day for reaching 70%
preference of the active operandum, which was 4.7 in males and
2.2 in females (Mann–Whitney U test, p= 0.014). The mainte-
nance phase of the food self-administration was evaluated as a
mean number of self-administered pellets during the last 5 days
when the intake was stable. Figure 5 depicts the significantly
higher pellet intake in female rats as compared to males (138–175
and 51–73, respectively, p 0.05).
Discussion
Findings of the present study demonstrated that male and female
rats had equal basal locomotor and exploratory activity. Thus,
differences in operant IV self-administration cannot be accounted
for differences in locomotor activity. Furthermore, the food self-
administration has shown a very different dynamics than the
METH study, suggesting higher motivation to obtain natural
reward (sweet pellet) in females, which learned the operant pro-
cedure faster (acquisition) and self-administered approximately
three times more pellets than males. This behavior toward natural
reward is very different from METH-related operant behavior,
which rules out the possibility of general gender specific difference
in the reward processes.
During the maintenance phase of the METH self-
administration, female rats were found to self-administer
the same number of infusion, but their METH intake in terms of
dose per kilogram of body weight was found lower. This measure
is not widely used among the self-administration studies, usually
only the numbers of nose pokes (or lever presses) and infusions
are reported. However, we propose this measure to be considered
as highly valid for several reasons. Despite the solution of the
drug being available in the operant box matches the body weight
of the particular animal, the solutions are prepared for certain
body weight category, e.g., solution for animal weighting 300 g
can be used for rats reaching approximately 280–320 g (this fact
is usually not described exactly in the Section “Materials and
Methods” of the papers). This discrepancy, aggravated by the
fact that the body weight of the animal changes over the course
of the experiment, could be a source of significant differences
in the dose taken even at conditions of the same number of
infusions. This is a confounding factor, which complicates the
comparison of findings from different laboratories. Furthermore,
this approach should be used when the number of behavioral
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FIGURE 2 | Acquisition and maintenance of methamphetamine intake in
male and female rats. The (A) part shows number of infusions expressed as
daily means over the 14 days of acquisition and maintenance of the METH IV
self-administration. The bar graph depicts the mean number of infusions over
the whole 14 days period. There were no statistically significant differences in
this measure (mixed ANOVA model). The (B) part shows in an analogical way
the mean dose in milligram per kilogram of METH self-administered by male
(n= 6) and female (n=6) rats. The groups start to differ significantly from the
day 10 with t-test results: day 10 (p= 0.021), day 11 (p= 0.049), and day 14
(p= 0.048). The bar graph shows the mean number of infusions over the last
5 days of the maintenance period (day 10–14) when the drug intake started to
be significantly higher in male rats (p= 0.038, mixed ANOVA model).
FIGURE 3 | Reinstatement of methamphetamine seeking behavior in
male and female rats. The graphs show a percent of mean basal
nose-poking (14 days of acquisition and maintenance) and number of
nose-pokes in the reinstatement session in male and female rats. There was
a statistically significant difference between the sexes in both measures:
male rats showed mean % of responding 48.3% and females 295.7%
(mixed ANOVA model, p= 0.001). The apparent difference between the
sexes is further confirmed by behavioral activity reflected in a mean number
of nose-pokes: 41.0 in males and 136.5 in females (mixed ANOVA model,
p= 0.006).
responses (nose pokes or lever presses) does not match the
number of infusions delivered. This is always the case when the
system uses nose poke operandi (and in some cases levers which
do not retract after infusion delivery).
Previous studies have shown that female rats to be more vul-
nerable to behavioral effects of psychomotor stimulants including
cocaine (36–38) and, in particular, amphetamines (including
METH), which elicited a higher increase of locomotion in females
than males or reach the same behavior profile at lower dose (25,
28, 39, 40). Other studies have repeatedly shown that females
with intact gonads tend to develop readily behavioral sensitiza-
tion to psychostimulant drugs after repeated treatment (41–43).
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FIGURE 4 | Acquisition of food self-administration behavior in male
and female rats. The (A) part shows the course of the active nose poke
preference development during acquisition and maintenance of the food
self-administration. The bar graph (B) depicts the mean day the animals
reached and kept 70% preference of the active operandum: 4.7 in males and
2.2 in females (Mann–Whitney U test, p= 0.014).
FIGURE 5 |Maintenance of food self-administration in male and
female rats. The graph shows pellet intake in female rats as compared to
males (t-test, *p0.05, ***p0.001).
Furthermore, there is new evidence of specific pharmacokinetic
differences in METH self-administration studies, where males
were shown to have lower area under curve (AUC) ofMETHprob-
ably due to rapid drug elimination (29). The apparent higher effi-
cacy of the amphetamines found in this and previouslymentioned
studies in female rats could be explained by the pharmacokinetic
differences.
Similarly, in clinical studies, there has been shown that men
are more sensitive to the reinforcing effects of a high dose of
-amphetamine than women, who respond rather to low doses at
a randomphase of themenstrual cycle (44). This is consistent with
our data, which showed that males developed higher stable intake
of METH than females (2.5 and 1.5mg/kg daily, respectively).
Furthermore, women were shown to experience greater increases
in diastolic pressure and nausea than men at the same doses while
the ability to discriminate -amphetamine was equal in both sexes
(45). These lines of evidence further support translational validity
of our finding of lower METH intake in female rats.
However, in fixed ratio self-administration paradigms, the
reports on gender differences in the maintenance phase are
numerous and quite contradictory in both clinical (45, 46) and
preclinical studies, showing both higher and lower drug intake in
female subjects (21, 47).
Progressive ratio IV self-administration paradigmor prolonged
access to the drug might be better tools to unravel gender differ-
ences as these may be linked to appetitive behavior (21). Female
rats have been repeatedly shown to achieve higher breaking points
in METH self-administration study suggesting higher motivation
to obtain the drug (10, 48). This is consistent with the robust gen-
der difference in the reinstatement found in this study, where the
motivation of animals for the drug-seeking was not abolished by
extinction training. At this point, active responses to the operan-
dum are the only measure to report because the session is per-
formed without delivering the drug.We found a highly significant
difference in the percent of mean basal nose-poking, as well as in
the absolute number of active operant responses. The enhancing
effect of estradiol and attenuating effects of progesterone on psy-
chostimulant (-amphetamine, METH, cocaine) intake in female
gender is repeatedly and consistently reported in both clinical
(49–52) and preclinical studies (17, 20–22). Therefore, the higher
variability in the reinstatement operant responding in the female
group detected in this study probably originated from different
hormonal stage. This conclusion can be supported by an earlier
study, which employed the extinction and both drug- and cue-
primed reinstatement, where females were foundmore vulnerable
in both reinstatement procedures and also exhibited higher vari-
ability than males. Interestingly, the numbers of lever presses in
the conditioned cue-primed reinstatement session were approxi-
mately 40 in males and 120 in females (10). These absolute num-
bers are similar to those reported in the present study: 41 and 136,
respectively. Therefore, this effect seems to be well reproducible
and strain independent (Long-Evans vs. Sprague-Dawley rats).
The forced abstinence model was proposed as a potentially
better tool to model a spontaneous relapse in rodents (15, 53).
To our knowledge, this is the first report of gender differ-
ences in the paradigm of reinstatement after forced abstinence.
Extinction-based approach to study relapse-like behavior phase
in the preclinical setting show contradictory results – females
appear to meet the extinction criteria later than males (11), but
negative results have been reported as well (54). Both studies were
conducted with cocaine.
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Taken together, this study reports lower consummatoryMETH
intake during maintenance phase of the self-administration
together with higher vulnerability to the reinstatement of METH
seeking behavior in female rats after forced abstinence. These
effects seem to be robust enough, thus relatively independent on
the current hormonal level. Therefore, we propose this paradigm
for preclinical screening for potential newmedications specific for
women. However, the main limitation for the translation of these
results to human medicine is the absence of psychosocial aspects,
which are impossible to reflect in animal studies.
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